Connect with us

Hi, what are you looking for?

BioTechnology

Brain Implants With The Potential To Restore Vision To The Blind

The ability to restore vision is one of the holy grails of regenerative medicine.

Brain Implants With The Potential To Restore Vision To The Blind

Thanks to the work of scientists from the University Miguel Hernández, we are now further along the way to restoring vision for the blind. In October, Fernández et al. successfully implanted an array of microelectrodes into the visual cortex of a fifty-seven-year-old woman who has been fully blind for the past sixteen years. After training, the woman could visualize several complex patterns and identify some letters. This demonstrated the potential of array microelectrodes for restoring some form of rudimentary vision.

The ability to restore vision is one of the holy grails of regenerative medicine. I have previously written about the potential of optogenetics in this field, but this study presents real progress for an approach using direct electrical stimulation in the brain instead.

Close your eyes and rub your eyelids. What do you see? Most people will report seeing multi-colored dots or patterns of light. These dots of light are called phosphenes and are what researchers aim to induce in blind patients as a form of rudimentary vision. Past studies have used electrical stimulation directly on the surface of the brain to induce phosphenes in blind individuals. However, there were significant limitations to this approach. When multiple electrodes were stimulated at the same time, the phosphenes would blur together rather than create two distinct shapes or dots. This made shape recognition difficult, if not impossible.

In addition, high levels of electrical current were required to even begin to stimulate phosphenes. This limited the clinical application of electrical stimulation in vision because high levels of current have the potential to damage neurons or induce seizures.

To address these issues, Fernández et al. experimented with an array of electrodes that penetrate deeper into the brain. The theory was that if the electrodes could initiate the activity of neurons deeper in the visual cortex, they would not require as much current to induce phosphenes in the patient’s vision. Electrodes with less current could also safely be placed closer together and potentially increase visual resolution. This would allow patients to distinguish discrete shapes and patterns.Microelectrode array and implantation.

Recent experimentation provided an optimistic foundation for the penetrative electrode array system. The device was successfully implanted in monkeys and allowed them to recognize simple shapes, motions, and letters.

One complication of electrically induced phosphenes in blind patients is that blind patients often already experience spontaneous phosphenes on a regular basis. The first step of the electrode implant experimentation was to see if the patient could discriminate between a spontaneous phosphene and an electrically induced one. To test this, researchers used an auditory tone that they played before they induced an electrical signal and when they were not inducing a signal. The patient would press a button if she thought that she saw an electrically induced phosphene after the tone. After two months of daily experimentation, the patient began to reliably differentiate between the two and correctly identified 947 out of 1000 electrically induced phosphenes.

One of the more crucial aspects of the experiment was whether penetrative electrode arrays produced higher resolution images. To test this, researchers ran stimulation experiments with 50 pairs of electrodes. They found that in 23.6% of the stimulations, the patient saw two discrete phosphene images. Surprisingly, electrodes that were just 400 micrometers apart were able to generate separate perceptions. These results demonstrate that the penetrative electrode array can achieve distinct images with electrodes that are five times closer than what has been achieved with direct surface stimulation, marking a vast improvement from previous methods.

Fernández et al. also found that the timing of electrode stimulation could be used to produce discrete images. This could be useful when attempting to produce more complicated patterns that are recognizable to the patient.

Further testing on the relationship between electrode current and the color and brightness of phosphenes showed that greater currents produced brighter and whiter light while smaller currents produced phosphenes that were sepia in color and much dimmer. The patient could accurately differentiate between currents based on color and brightness.

After determining the characteristics of vision produced by penetrative electrode arrays, researchers were ready to test the patient with complex, 2D patterns. They simultaneously stimulated combinations of 3 to 16 electrodes at a time to produce patterned stimuli. The patient would then draw what she saw. The overall success rate of these pattern recognition experiments was 81.4% and improved as training continued.Pattern recognition test results.

Motivated by the success of these results, Fernández et al. then tested the patient’s ability to recognize letters using the same experimental model. The patient was able to consistently recognize some letters such as “I”, “L”, “C”, “V”, and “O”, but was inconsistent or unable to recognize others. Overall, her success rate for each trial always exceeded 70%.Letter recognition test results.

Finally, to delve into the clinical applications of a penetrative microelectrode array system, researchers experimented with a bio-inspired retina-like visual encoder. The visual encoder is a pair of glasses that features a camera. The camera acts as an artificial retina. It records visual inputs in real-time and translates them into electrode stimulation patterns that can cause accurate phosphene visualizations in the patient. To investigate how the visual encoder could work with the microelectrode array system, the patient used the visual encoder to scan an image of black and white bars printed on cardboard. She was then asked to locate the borders between the black and white bars. They then repeated similar experiments using images on a computer monitor. After just 2 days of training, the patient was able to correctly locate features of an image 100% of the time.Bio-inspired retina-like visual encoder.

Irrespective of damage done to the structures of the eye or the retina, this study offers a direct way of interfacing the visual world with the brain. The combination of neuroscience, microelectronics, and miniaturized high-powered computation is what made this study possible. These three fields are advancing at record speeds. As we develop a deeper understanding of each field, we can anticipate substantial progress in restoring vision to those with optical damage or even to those who have lost their eyes, through the technology of direct brain stimulation.

Seen on Forbes (Innovation): Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Diagnostics

PocDoc, the digital health platform and personal diagnostics provider, has launched what it says is a world-first smartphone-based test for cardiovascular disease.

HealthTech

Focused on connecting startups in the Medtech industry with potential investors, this can't miss event features the globe's most promising companies

BioTechnology

The technology could greatly aid spinal surgeons in planning surgical interventions in advance.   

Exclusives

Emerging HealthTech company, Stasis Labs, Inc. intends to bridge the gap between clinicians and their patients with an all-in-one FDA-cleared hardware and software solution,...

You May Also Like

Exclusives

Today & Tomorrow: Digital Solutions in HealthTech Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare...

Exclusives

In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...

Exclusives

Software as a Medical Device (SaMD) is driving innovation in the HealthTech space and is more popular than ever — completely upending the way...

Exclusives

The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.